Logo image of LIZI

LIZHI INC (LIZI) Stock Fundamental Analysis

NASDAQ:LIZI - US53933L2034 - ADR

2.8 USD
+0.06 (+2.19%)
Last: 1/24/2024, 8:00:03 PM
2.89 USD
+0.09 (+3.21%)
After Hours: 1/24/2024, 8:00:03 PM
Fundamental Rating

5

Taking everything into account, LIZI scores 5 out of 10 in our fundamental rating. LIZI was compared to 74 industry peers in the Entertainment industry. LIZI has an average financial health and profitability rating. LIZI is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make LIZI suitable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

LIZI had positive earnings in the past year.
In the past 5 years LIZI reported 4 times negative net income.
In multiple years LIZI reported negative operating cash flow during the last 5 years.
LIZI Yearly Net Income VS EBIT VS OCF VS FCFLIZI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 0 -200M -400M -600M -800M -1B

1.2 Ratios

With an excellent Return On Assets value of 14.87%, LIZI belongs to the best of the industry, outperforming 97.26% of the companies in the same industry.
Looking at the Return On Equity, with a value of 23.66%, LIZI belongs to the top of the industry, outperforming 93.15% of the companies in the same industry.
LIZI has a better Return On Invested Capital (14.23%) than 93.15% of its industry peers.
Industry RankSector Rank
ROA 14.87%
ROE 23.66%
ROIC 14.23%
ROA(3y)-19.87%
ROA(5y)-183.51%
ROE(3y)-55.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LIZI Yearly ROA, ROE, ROICLIZI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 0 500 -500 1K 1.5K 2K

1.3 Margins

LIZI's Profit Margin of 4.79% is amongst the best of the industry. LIZI outperforms 80.82% of its industry peers.
LIZI has a Operating Margin of 3.72%. This is in the better half of the industry: LIZI outperforms 65.75% of its industry peers.
Looking at the Gross Margin, with a value of 31.28%, LIZI is in line with its industry, outperforming 41.10% of the companies in the same industry.
LIZI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.72%
PM (TTM) 4.79%
GM 31.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.69%
GM growth 5Y3.91%
LIZI Yearly Profit, Operating, Gross MarginsLIZI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 20 -20 -40 -60 -80

More info and screens

5

2. Health

2.1 Basic Checks

LIZI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, LIZI has more shares outstanding
The debt/assets ratio for LIZI has been reduced compared to a year ago.
LIZI Yearly Shares OutstandingLIZI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M
LIZI Yearly Total Debt VS Total AssetsLIZI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.35, we must say that LIZI is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.35, LIZI perfoms like the industry average, outperforming 46.58% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that LIZI is not too dependend on debt financing.
LIZI's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. LIZI outperforms 78.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.35
ROIC/WACC1.94
WACC7.35%
LIZI Yearly LT Debt VS Equity VS FCFLIZI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 100M -100M 200M 300M

2.3 Liquidity

LIZI has a Current Ratio of 2.58. This indicates that LIZI is financially healthy and has no problem in meeting its short term obligations.
LIZI has a better Current ratio (2.58) than 80.82% of its industry peers.
A Quick Ratio of 2.58 indicates that LIZI has no problem at all paying its short term obligations.
The Quick ratio of LIZI (2.58) is better than 80.82% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.58
LIZI Yearly Current Assets VS Current LiabilitesLIZI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 200M 400M 600M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1683.33% over the past year.
LIZI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.31%.
The Revenue has been growing by 36.96% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1683.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)13.31%
Revenue growth 3Y22.78%
Revenue growth 5Y36.96%
Sales Q2Q%14.97%

3.2 Future

Based on estimates for the next years, LIZI will show a very negative growth in Earnings Per Share. The EPS will decrease by -48.05% on average per year.
The Revenue is expected to grow by 114.98% on average over the next years. This is a very strong growth
EPS Next Y-96.37%
EPS Next 2Y-68.59%
EPS Next 3Y-48.05%
EPS Next 5YN/A
Revenue Next Year747.7%
Revenue Next 2Y209.26%
Revenue Next 3Y114.98%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LIZI Yearly Revenue VS EstimatesLIZI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
LIZI Yearly EPS VS EstimatesLIZI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 0.92, the valuation of LIZI can be described as very cheap.
100.00% of the companies in the same industry are more expensive than LIZI, based on the Price/Earnings ratio.
LIZI is valuated cheaply when we compare the Price/Earnings ratio to 27.24, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 10.34, which indicates a very decent valuation of LIZI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LIZI indicates a rather cheap valuation: LIZI is cheaper than 89.04% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.82, LIZI is valued rather cheaply.
Industry RankSector Rank
PE 0.92
Fwd PE 10.34
LIZI Price Earnings VS Forward Price EarningsLIZI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -5.38
LIZI Per share dataLIZI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

A cheap valuation may be justified as LIZI's earnings are expected to decrease with -48.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.59%
EPS Next 3Y-48.05%

More info and screens

0

5. Dividend

5.1 Amount

LIZI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIZHI INC

NASDAQ:LIZI (1/24/2024, 8:00:03 PM)

After market: 2.89 +0.09 (+3.21%)

2.8

+0.06 (+2.19%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-14 2023-11-14/bmo
Earnings (Next)03-14 2024-03-14/amc
Inst Owners1.35%
Inst Owner Change-40.01%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.82M
Analysts85.71
Price Target1.43 (-48.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 0.92
Fwd PE 10.34
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 0.22
P/tB 0.22
EV/EBITDA -5.38
EPS(TTM)3.04
EY108.57%
EPS(NY)0.27
Fwd EY9.67%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS62.58
BVpS12.66
TBVpS12.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 14.87%
ROE 23.66%
ROCE 18.29%
ROIC 14.23%
ROICexc N/A
ROICexgc N/A
OM 3.72%
PM (TTM) 4.79%
GM 31.28%
FCFM N/A
ROA(3y)-19.87%
ROA(5y)-183.51%
ROE(3y)-55.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.69%
GM growth 5Y3.91%
F-ScoreN/A
Asset Turnover3.11
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA 0.07
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.58
Quick Ratio 2.58
Altman-Z 0.35
F-ScoreN/A
WACC7.35%
ROIC/WACC1.94
Cap/Depr(3y)93.44%
Cap/Depr(5y)138.6%
Cap/Sales(3y)1.02%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1683.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y-96.37%
EPS Next 2Y-68.59%
EPS Next 3Y-48.05%
EPS Next 5YN/A
Revenue 1Y (TTM)13.31%
Revenue growth 3Y22.78%
Revenue growth 5Y36.96%
Sales Q2Q%14.97%
Revenue Next Year747.7%
Revenue Next 2Y209.26%
Revenue Next 3Y114.98%
Revenue Next 5YN/A
EBIT growth 1Y1575%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-82.2%
EBIT Next 3Y15.08%
EBIT Next 5YN/A
FCF growth 1Y303.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y437.38%
OCF growth 3YN/A
OCF growth 5YN/A